CClinicalTrials.gg
RecruitingNCT04911738VIRGILUpdated May 21, 2025

VIrtual Reality Glasses Use to Improve Lateropulsion and the Post-stroke Postural Vertical

An interventional study of Virtual Reality , immersion in a virtual titlted room in Stroke, Brain Diseases and Cerebrovascular Disorders, sponsored by University Hospital, Grenoble. Recruiting at 1 site in France. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-21.

Sponsored by University Hospital, Grenoble · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Jun 2021; still recruiting 5 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

VIRGIL is a monocentric interventional study aiming to investigate the effect of immersion in a virtual tilted room on modulation of the verticality representation (postural vertical [PV] and visual vertical [VV]), which in turn might affect body orientation (head and trunk). To this end, the investigators will conduct a within-person randomized trial including post-stroke patients and healthy participants.

Read the detailed description

This project proposes to test the effect of immersion in a tilted virtual reality on verticality representation in hemisphere stroke patients showing lateropulsion and in healthy participants. The idea is to use the virtual reality as a tool to recalibrate the internal reference of verticality (contralesionally biased) in stroke patients and to experimentally create a bias in verticality perception of healthy participants, then to investigate how this modulation of the internal model of verticality might affect the erect posture. The investigators hypothesize that, in stroke patients, the recalibration of the verticality perception might ameliorate their lateropulsion, whereas in healthy participants, the experimental verticality bias introduced might induce a transient experimental lateropulsion. A transmodal modulation of the verticality perception, both on PV and VV, would imply a modulation by the virtual reality not only at the level of perception but also at the internal model of verticality, advocating for a powerful effect of this technology. The analysis of a post-effect (on verticality perception) that would continue after the intervention (immersion in the virtual titled room) would be a supplementary argument advocating for its clinical use in rehabilitation of post-stroke lateropulsion. To judge the effect of the immersion in tilted virtual reality, the following measures will be considered: (a) PV perception, (b) VV perception, (c) body orientation measured by inertial captors, and (d) weight-bearing asymmetry in erect posture assessed by posturography.

02

Conditions studied

  • Stroke
  • Brain Diseases
  • Cerebrovascular Disorders
  • Postural; Defect
  • Cognition Disorder

Keywords

  • Lateropulsion
  • Verticality representation
  • Virtual reality
  • Rehabilitation
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 40 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University Hospital, Grenoble is the lead sponsor of 815 studies on the registry; 205 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 20 stroke participants

    • Hospitalized in neurorehabilitation
    • Hemisphere stroke (Right or left)
    • Stroke delay \< 6 months
    • Presence of lateropulsion assessed by the Scale for Contraversive Pushing (SCP) > 0.5
  • 20 healthy participants

    • No history of stroke or others neurological pathologies
    • No balance disorders
    • No history of vestibular or dizzissness disorders

Exclusion criteria

Exclusion Criteria:

  • All

    • History of psychiatric disorders
    • Nyctophobia
    • Advanced heart failure
    • Severe trunk deformation with C7 lateral > 30 mm due to a independant cause beyond the stroke (i.e., scoliosis) or history of postural disorder
  • 20 Stroke participants

    • Medical instability making the assessment impossible
    • Comprehension deficits with Boston Diagnostic Aphasia Examination gravity score ≥3
    • History of vestibular or dizzissness disorders
    • No previous neurological history interfering with balance
    • Inability to understand and execute simple orders
    • Severe untreated depression (Aphasic Depression Rating Scale (ADRS) score >15)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Plane A for the cross-over (Immersion in a virtual tilted room)

    Half of participants will perform the experiment according the plane A, which corresponds to the following order: verticality perception (Baseline, effect during the intervention, post-effect), then active vertical body orientation (Baseline, effect during the intervention). The intervention is an immersion in a virtual static and tilted environnement (18°). During the intervention, participants will be immersed in a virtual tilted room for 15 minutes (after 5 minutes of pre -installation adjustments), then verticality perception or active body orientation assessments are performed while the participant is still virtually immersed (approximately 25 minutes). Participants will be immersed in a tilted virtual room for 45 minutes each day.

    Other: Virtual Reality , immersion in a virtual titlted room

  • Experimental
    Plane B for the cross-over (Immersion in a virtual tilted room)

    Half of participants will perform the experiment according the plane B, which corresponds to the following order: active vertical body orientation (Baseline, effect during the intervention), then verticality perception (Baseline, effect during the intervention, post-effect). The intervention is an immersion in a virtual static and tilted environnement (18°). During the intervention, participants will be immersed in a virtual tilted room for 15 minutes (after 5 minutes of pre -installation adjustments), then verticality perception or active body orientation assessments are performed while the participant is still virtually immersed (approximately 25 minutes). Participants will be immersed in a tilted virtual room for 45 minutes each day.

    Other: Virtual Reality , immersion in a virtual titlted room

Interventions

  • OtherVirtual Reality , immersion in a virtual titlted room

    The immersion in virtual reality will be based on the HTC VIVE® device and the software developed by the Virtualis Society.

06

What researchers measure

Primary outcomes

  1. Changes in the postural perception of the vertical (PV) before and during the immersion in a virtual tilted room, in stroke and healthy participants.

    PV consists of testing the whole body orientation in sitting, perceived as vertical by participants, in complete darkness. PV will be tested by a well-validated apparatus and paradigm (Pérennou et al Brain 2008). PV orientation will be the average orientation (in degree) of the 10 trials performed for each condition.

    Time frame: Days 1 and 3 if assignment to plane A or days 2 and 4 if assignment to plane B of the W2

Secondary outcomes

  1. Changes in the visual perception of the vertical (VV) before and during the immersion in a virtual tilted room, in stroke and healthy participants.

    VV consists of testing the direction of a visual line, perceived as vertical by particpants, in complete darkness. VV will be tested by a well-validated apparatus and paradigm (Pérennou et al Brain 2008 ; Piscicelli \& Pérennou 2017). VV orientation will be the average orientation (in degree) of the 10 trials performed for each condition.

    Time frame: Days 1 and 3 if assignment to plane A or days 2 and 4 if assignment to plane B of the W2

  2. Post-effect on PV. Change from baseline in PV orientation that continues after the immersion in virtual reality, in stroke and healthy participants.

    Persistence of PV improvement in stroke participants and persistence of PV change in healthy participants, for at least 20 minutes after the virtual reality is stopped until a maximum of 1 hour.

    Time frame: Days 1 and 3 if assignment to plane A or days 2 and 4 if assignment to plane B of the W2

  3. Post-effect on VV. Change from baseline in VV orientation that continues after the immersion in virtual reality, in stroke and healthy participants.

    Persistence of VV improvement in stroke participants and persistence VV change in healthy participants, for at least 20 minutes after the virtual reality is stopped until a maximum of 1 hour.

    Time frame: Days 1 and 3 if assignment to plane A or days 2 and 4 if assignment to plane B of the W2

  4. Modulation of active vertical trunk orientation. Change from baseline in active vertical trunk orientation assessed by inertial captors during the modulation of the internal model of verticality by virtual reality, in stroke and healthy participants.

    Comparison between active vertical trunk orientation assessed by inertial captors at baseline and active vertical trunk orientation during the virtual reality immersion.

    Time frame: Days 2 and 4 if assignment to plane A or days 1 and 3 if assignment to plane B of the W2

  5. Modulation of active vertical pelvis orientation. Change from baseline in active vertical trunk orientation assessed by inertial captors during the modulation of the internal model of verticality by virtual reality, in stroke and healthy participants.

    Comparison between active vertical pelvis orientation assessed by inertial captors at baseline and active vertical pelvis orientation during the virtual reality immersion.

    Time frame: Days 2 and 4 if assignment to plane A or days 1 and 3 if assignment to plane B of the W2

  6. Modulation of active vertical head orientation. Change from baseline in active vertical head orientation assessed by inertial captors during the modulation of the internal model of verticality by virtual reality, in stroke and healthy participants.

    Comparison between active vertical head orientation assessed by inertial captors at baseline and active vertical head orientation during the virtual reality immersion.

    Time frame: Days 2 and 4 if assignment to plane A or days 1 and 3 if assignment to plane B of the W2

  7. Effect on lateropulsion. Change from baseline in lateropulsion scores assessed by the SCAle for LAteropulsion after 4 consecutive half days of verticality referential recalibration by virtual reality, in stroke participants.

    Comparison of lateropulsion scores assessed by the SCAle for LAteropulsion (SCALA-scale, score from 0 (no lateropulsion) to 50 (severe lateropulsion with pushing); higher scores mean a worse outcome) at the end of each week (Fridays).

    Time frame: 45 minutes every Friday during the protocol (W0, W1, W2, W3).

  8. Effect on postural capacities. Change from baseline in balance scores assessed by the modified Postural Assessment Scale for Stroke patient after 4 consecutive half days of verticality referential recalibration by virtual reality, in stroke participants

    Comparison of balance scores assessed by the modified Postural Assessment Scale for Stroke patient (m-PASS, score from 0 (major postural disorders) to 36 (no postural disorder), higher scores mean a worse outcome) at the end of each week (Fridays).

    Time frame: 45 minutes every Friday during the protocol (W0, W1, W2, W3).

  9. Responders to virtual reality. Proportion of participants in whom the immersion in a virtual tilted room modulates PV (at least 2 degrees).

    Number of participants, stroke and healthy, in whom a change from baseline ≥ 2 degrees in PV orientation was observed during immersion in a virtual tilted room. The investigators hypothesize that the majority of participants (stroke and healthy) will be responders

    Time frame: Days 1 and 3 if assignment to plane A or days 2 and 4 if assignment to plane B of the W2

  10. Changes in weight-bearing asymmetry. Evaluation of changes in weight-bearing asymmetry in standing posture before and during the immersion in a virtual tilted room, in stroke and healthy participants.

    Weight-bearing asymmetry assessed by posturography at baseline and during virtual reality, in patients and healthy participants. Comparison of both conditions.

    Time frame: Days 2 and 4 if assignment to plane A or days 1 and 3 if assignment to plane B of the W2

  11. Awareness of the changes in active vertical body orientation. Evaluation of participants' awareness of the changes in body orientation and balance in standing posture induced by virtual reality.

    Perception of the body orientation change under virtual reality assessed by a 5-point Likert scale (ad-hoc scale, score from -2 \[perception of a higher lateropulsion\] to + 2 \[perception of a less severe lateropulsion\])

    Time frame: Days 2 and 4 if assignment to plane A or days 1 and 3 if assignment to plane B of the W2

  12. Relationship between the trunk tilt (assessed by inertial captors, in degrees) and the weight bearing on the paretic side (in percentage of body weight), at baseline, with average values (2 sessions)

    Active vertical body orientation measures and weight-bearing asymetry before virtual reality.

    Time frame: Days 2 and 4 if assignment to plane A or days 1 and 3 if assignment to plane B of the W2

  13. Relationship between the trunk tilt (assessed by inertial captors, in degrees) and the weight bearing on the paretic side (in percentage of body weight), during the virtual reality, with average values (2 sessions).

    Active vertical body orientation measures and weight-bearing asymetry during virtual reality.

    Time frame: Days 2 and 4 if assignment to plane A or days 1 and 3 if assignment to plane B of the W2

  14. Quantification of a possible Virtual reality sickness.

    Systematic evaluation of virtual reality sickness with a visual analogical scale (ad-hoc scale, from 0 to 10, higher scores mean a worse outcome).

    Time frame: Days 1, 2, 3 and 4 of the W2

  15. Description of symptoms in case of Virtual reality sickness.

    Systematic evaluation of virtual reality sickness with a structured interview.

    Time frame: Days 1, 2, 3 and 4 of the W2

  16. Influence of verbal instruction on standing posture

    Active vertical body orientation measures under three verbal conditions: : i) stand comfortably; ii) stand vertical and then iii) stand well symmetrical by distributing the weight equally between the two lower limbs.

    Time frame: Days 1, 2, 3 and 4 of the W2

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Perennou DA, Mazibrada G, Chauvineau V, Greenwood R, Rothwell J, Gresty MA, Bronstein AM. Lateropulsion, pushing and verticality perception in hemisphere stroke: a causal relationship? Brain. 2008 Sep;131(Pt 9):2401-13. doi: 10.1093/brain/awn170. Epub 2008 Aug 4. PubMed 18678565 ↗
  • Piscicelli C, Perennou D. Visual verticality perception after stroke: A systematic review of methodological approaches and suggestions for standardization. Ann Phys Rehabil Med. 2017 Jun;60(3):208-216. doi: 10.1016/j.rehab.2016.02.004. Epub 2016 Apr 11. PubMed 27079584 ↗
  • Odin A, Faletto-Passy D, Assaban F, Perennou D. Modulating the internal model of verticality by virtual reality and body-weight support walking: A pilot study. Ann Phys Rehabil Med. 2018 Sep;61(5):292-299. doi: 10.1016/j.rehab.2018.07.003. Epub 2018 Jul 19. PubMed 30031891 ↗
  • Dai S, Piscicelli C, Clarac E, Baciu M, Hommel M, Perennou D. Balance, Lateropulsion, and Gait Disorders in Subacute Stroke. Neurology. 2021 Apr 27;96(17):e2147-e2159. doi: 10.1212/WNL.0000000000011152. Epub 2020 Nov 11. PubMed 33177223 ↗

Individual participant data

Plan to share: Yes — Anonymized data that support the findings of this study are available from the corresponding author, upon reasonable request, only for authorized research. Their use is subjected to an agreement with the promotor (CHU Grenoble Alpes) and the principal investigator (Pr Dominic Pérennou) of the VIRGIL study. Pseudonymised data that support the findings of this study are available from the promotor (CHU Grenoble Alpes) upon reasonable request, subject to a specific agreement with the promotor (involving the principal investigator) and subject to regulatory proceedings due to data protection applicable laws. Access conditions are to be determined depending on the nature of the request

Supporting information: Study protocol, Sap, Icf

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04911738
Lead sponsor
University Hospital, Grenoble
Collaborators
Fondation Paul Bennetot
Responsible party
Sponsor
First posted
Jun 3, 2021
Start date
Jun 15, 2021
Primary completion
Mar 31, 2026 (estimated)
Completion
May 30, 2026 (estimated)
Last update
May 21, 2025

Study contacts

Dominic Pérennou
Contact
DPerennou@chu-grenoble.fr
+33 476766084
Dominic Pérennou
principal investigator · University Hospital, Grenoble

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion